Literature DB >> 3326577

Adrenal haemorrhage presenting as an abdominal mass in the newborn.

J E Wright, J W Bear.   

Abstract

Adrenal haemorrhage in the newborn, an entity well recognized at autopsy and as a cause of massive haemorrhage, may present as an asymptomatic abdominal mass. Three cases of neonatal adrenal haemorrhage are described and the literature is reviewed. Most of the affected babies were of normal birthweight, full term and with no history of difficult delivery or neonatal asphyxia. Most presented with a flank mass and jaundice. The haemoglobin was not always low. Intravenous urography and sonography were the investigations of choice. The most serious condition in the differential diagnosis is neuroblastoma, but the chance of this presenting in the newborn period with normal catecholamine secretion and no evident metastases is sufficiently rare to justify expectant management. Follow-up physical examination and repeat sonography at 1 month are recommended. This interval is long enough to allow resolution of a mass caused by adrenal haemorrhage.

Entities:  

Mesh:

Year:  1987        PMID: 3326577     DOI: 10.1111/j.1440-1754.1987.tb00278.x

Source DB:  PubMed          Journal:  Aust Paediatr J        ISSN: 0004-993X


  3 in total

1.  Neonatal adrenal hemorrhage presenting as late onset neonatal jaundice.

Authors:  Umar Amin Qureshi; Nisar Ahmad; Akhter Rasool; Suhail Choh
Journal:  J Indian Assoc Pediatr Surg       Date:  2009-10

Review 2.  Cystic adrenal lesions: focus on pediatric population (a review).

Authors:  Mara Carsote; Adina Ghemigian; Dana Terzea; Ancuta Augustina Gheorghisan-Galateanu; Ana Valea
Journal:  Clujul Med       Date:  2017-01-15

3.  Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a.

Authors:  Joana Vitallé; Iñigo Terrén; Leire Gamboa-Urquijo; Ane Orrantia; Laura Tarancón-Díez; Miguel Genebat; Manuel Leal; Ezequiel Ruiz-Mateos; Francisco Borrego; Olatz Zenarruzabeitia
Journal:  Sci Rep       Date:  2020-04-08       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.